Literature DB >> 16476726

Prohormone convertase 1/3 is essential for processing of the glucose-dependent insulinotropic polypeptide precursor.

Randi Ugleholdt1, Marie-Louise H Poulsen, Peter J Holst, Jean-Claude Irminger, Cathrine Orskov, Jens Pedersen, Mette M Rosenkilde, Xiaorong Zhu, Donald F Steiner, Jens J Holst.   

Abstract

The physiology of the incretin hormones, glucagon-like peptide 1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), and their role in type 2 diabetes currently attract great interest. Recently we reported an essential role for prohormone convertase (PC) 1/3 in the cleavage of intestinal proglucagon, resulting in formation of GLP-1, as demonstrated in PC1/3-deficient mice. However, little is known about the endoproteolytic processing of the GIP precursor. This study investigates the processing of proGIP in PC1/3 and PC2 null mice and in cell lines using adenovirus-mediated overexpression. Supporting a role for PC1/3 in proGIP processing, we found co-localization of GIP and PC1/3 but not PC2 in intestinal sections by immunohistochemistry, and analysis of intestinal extracts from PC1/3-deficient animals demonstrated severely impaired processing to GIP, whereas processing to GIP was unaltered in PC2-deficient mice. Accordingly, overexpression of preproGIP in the neuroendocrine AtT-20 cell line that expresses high levels of endogenous PC1/3 and negligible levels of PC2 resulted in production of GIP. Similar results were obtained after co-expression of preproGIP and PC1/3 in GH4 cells that express no PC2 and only low levels of PC1/3. In addition, studies in GH4 cells and the alpha-TC1.9 cell line, expressing PC2 but not PC1/3, indicate that PC2 can mediate processing to GIP but also to other fragments not found in intestinal extracts. Taken together, our data indicate that PC1/3 is essential and sufficient for the production of the intestinal incretin hormone GIP, whereas PC2, although capable of cleaving proGIP, does not participate in intestinal proGIP processing and is not found in intestinal GIP-expressing cells.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16476726     DOI: 10.1074/jbc.M601203200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  24 in total

1.  Enteroendocrine K and L cells in healthy and type 2 diabetic individuals.

Authors:  Tina Jorsal; Nicolai A Rhee; Jens Pedersen; Camilla D Wahlgren; Brynjulf Mortensen; Sara L Jepsen; Jacob Jelsing; Louise S Dalbøge; Peter Vilmann; Hazem Hassan; Jakob W Hendel; Steen S Poulsen; Jens J Holst; Tina Vilsbøll; Filip K Knop
Journal:  Diabetologia       Date:  2017-09-28       Impact factor: 10.122

Review 2.  Physiology of incretins in health and disease.

Authors:  Carolyn F Deacon; Bo Ahrén
Journal:  Rev Diabet Stud       Date:  2011-11-10

3.  GIP(3-30)NH2 is an efficacious GIP receptor antagonist in humans: a randomised, double-blinded, placebo-controlled, crossover study.

Authors:  Lærke S Gasbjerg; Mikkel B Christensen; Bolette Hartmann; Amalie R Lanng; Alexander H Sparre-Ulrich; Maria B N Gabe; Flemming Dela; Tina Vilsbøll; Jens J Holst; Mette M Rosenkilde; Filip K Knop
Journal:  Diabetologia       Date:  2017-09-25       Impact factor: 10.122

4.  Disruption of proprotein convertase 1/3 (PC1/3) expression in mice causes innate immune defects and uncontrolled cytokine secretion.

Authors:  Sarah Refaie; Sandra Gagnon; Hugo Gagnon; Roxane Desjardins; François D'Anjou; Pedro D'Orléans-Juste; Xiaorong Zhu; Donald F Steiner; Nabil G Seidah; Claude Lazure; Michel Salzet; Robert Day
Journal:  J Biol Chem       Date:  2012-03-06       Impact factor: 5.157

5.  A common variant upstream of the PAX6 gene influences islet function in man.

Authors:  E Ahlqvist; F Turrini; S T Lang; J Taneera; Y Zhou; P Almgren; O Hansson; B Isomaa; T Tuomi; K Eriksson; J G Eriksson; V Lyssenko; L Groop
Journal:  Diabetologia       Date:  2011-09-16       Impact factor: 10.122

6.  B Lymphocytes Express Pomc mRNA, Processing Enzymes and β-Endorphin in Painful Inflammation.

Authors:  Santhosh Chandar Maddila; Melanie Busch-Dienstfertig; Christoph Stein
Journal:  J Neuroimmune Pharmacol       Date:  2016-11-11       Impact factor: 4.147

Review 7.  Pro-protein convertases in intermediary metabolism: islet hormones, brain/gut hormones and integrated physiology.

Authors:  Dominique Bataille
Journal:  J Mol Med (Berl)       Date:  2007-03-14       Impact factor: 4.599

Review 8.  The role of incretins in glucose homeostasis and diabetes treatment.

Authors:  Wook Kim; Josephine M Egan
Journal:  Pharmacol Rev       Date:  2008-12-12       Impact factor: 25.468

9.  Biochemical and cell biological properties of the human prohormone convertase 1/3 Ser357Gly mutation: a PC1/3 hypermorph.

Authors:  Elias H Blanco; Juan R Peinado; Martín G Martín; Iris Lindberg
Journal:  Endocrinology       Date:  2014-06-16       Impact factor: 4.736

Review 10.  PCSK1 Variants and Human Obesity.

Authors:  B Ramos-Molina; M G Martin; I Lindberg
Journal:  Prog Mol Biol Transl Sci       Date:  2016-01-29       Impact factor: 3.622

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.